NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/03/2026
Voltar para busca
Dado oficial do USPTO
COURPENDY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
23
Atualização mais recente
25/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10
Data de depósito
02/06/2025
Data de registro
24/03/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/03/2026
Última transação
25/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Foreign priority
Código do desenho
4
Tipo de titular
65
Localização do titular
Valby, DK
Examinador
TARABAN, LAURA KRISTEN
Unidade examinadora
N90
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
H. Lundbeck A/S
Representantes
Maren Perry King & Spalding LLP
Classificação técnica
Classes Nice
Classe 5Classe 10
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Sanitary preparations for medical purposes; dietetic preparations for medical use; vaccines; pharmaceutical preparations and substances for the diagnosisprevention and treatment of psychiatricneurologicalneurohormonalneurogeneticneuroendocrinological and autoimmune diseases and disorders; pharmaceutical preparations and substances acting on the central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the diagnosisprevention and treatment of psychiatricneurologicalneurohormonalneurogeneticneuroendocrinological and autoimmune diseases and disorders; pharmaceutical preparations and substances for diagnosisprevention and treatment of dementiaAlzheimer's diseasedepressionpsychosisanxietyLennox-Gastaut diseaseepilepsyDravet SyndromeDevelopmental and Epileptic Encephalopathy (DEE)alpha-synucleinopathiesMultiple System Atrophy (MSA)dementia with Lewy bodiesrapid eye movement (REM) sleep behavior syndromeporphyriaHuntington's diseaseinsomniaParkinson's diseasesclerosismultiple sclerosisschizophreniabipolar disordercancerpainmigraineheadacheHorton's headachetraumatic brain injurypost-traumatic brain injurydizzinessseizuresstrokecognitive impairmentcognitive disorders and diseasesmood disordersfallsmovement disorders and diseasestremoragitationmaniaaggressionautismmelancholiaObsessive Compulsive Disorder (OCD)Tourette's syndromerestlessnessakathisiafatiguesomnolencenauseaCushing's diseaseAdrenogenital syndrome (AGS)narcolepsyPost-Traumatic Stress Disorder (PTSD)Attention Deficit Hyperactivity Disorder (ADHD)Progressive Supranuclear Palsy (PSP)Thyroid Associated Orbitopathy (TAO)Graves OrbitopathyHashimoto's Thyroiditisalcoholism and addiction; diagnostic agents and preparations for medical purposes; chemical substances for diagnostic and medical purposeschemical reagents for medical usediagnostic chemical reagents for medical purposes; medical diagnostic reagents
Classe 10
Medical apparatusinfusion and injection devices for administering drugs; medical syringesintravenous bags sold empty for intravenous therapyintravenous (IV) feeding tubesintravenous (IV) infusion pumpsintravenous (IV) catheters; injection devices for administering drugsmedical syringes and needles for injections and medical purposes; apparatus and instruments for diagnostic purposesdosage management dispensers for medicines also containing downloadable and recorded software for medical information management for use in web-based physical and psychological examination and assessment of patients at a distance and at a clinic; medical devices and instruments for the diagnosisadministrationmonitoringassessmentcontrol and examination of psychiatricneurologicalneurohormonalneurogeneticneuroendocrinological and autoimmune disorders and diseases; integrated medical systems for use with downloadable computer software comprised of medical instruments and recorded software sold in connection therewith for information and information management for use of a web-based physical and psychological and neurological examination and assessment of patients and clients; integrated medical systems comprised of medical devices and instruments for treating central nervous system diseases and disorders and psychiatricneurologicalneurohormonalneurogeneticneuroendocrinological and autoimmune disorders and diseasesall for the purposes of managementmeasurementmonitoringevaluationcontrolcollectionstoragetransmission and examination of patient and client data and information; medical instruments for providing medication administering informationguidancemanagement in the nature of devices for delivery and administering of medicines and infusion pumps
Publicações
Histórico de despachos e eventos da marca no USPTO.
23 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
24/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/02/2026
PUBO
PUBLISHED FOR OPPOSITION
03/02/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/01/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/01/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
08/01/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/01/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
08/01/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/01/2026
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/01/2026
GNFR
FINAL REFUSAL E-MAILED
02/01/2026
CNFR
FINAL REFUSAL WRITTEN
02/01/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/10/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
16/10/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/10/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
15/10/2025
GNRT
NON-FINAL ACTION E-MAILED
15/10/2025
CNRT
NON-FINAL ACTION WRITTEN
15/10/2025
DOCK
ASSIGNED TO EXAMINER
09/10/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/10/2025
MAFR
APPLICATION FILING RECEIPT MAILED
02/06/2025
NWAP
NEW APPLICATION ENTERED
02/06/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace COURPENDY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.